Endovascular Engineering (E2) announced today that it raised $42 million in an oversubscribed Series B financing round.

Huo said their results may someday be used to change treatment guidelines for stroke survivors who have undergone successful clot removal. “We still need to directly analyze the individual data ...

Huo said their results may someday be used to change treatment guidelines for stroke survivors who have undergone successful clot removal. "We still need to directly analyze the individual data of ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

In this trial, standard care was clot removal without clot-dissolving medication. The added treatment may work by dissolving blood clots in the small vessels (microcirculation) near the major ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 days after a stroke than standard care alone (including clot-busting ...

Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

Two studies show endovascular thrombectomy does not lead to better outcomes at 90 days or result in lower incidence of death. HealthDay News — (EVT) does not lead to better outcomes at 90 days ...